Skip to content

The effect of mealworm protein ingestion on muscle protein synthesis rates during recovery from endurance-type exercise in vivo in humans

The effect of mealworm protein ingestion on muscle protein synthesis rates during recovery from endurance-type exercise in vivo in humans - Insect protein and running (CENTURION)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON51585
Enrollment
30
Registered
2022-02-10
Start date
2022-06-03
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle anabolism Muscle growth

Interventions

Mealworm protein (bolus based on bodyweight) running

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: * Age between 18 and 35 y inclusive * BMI between 18.5 and 30 kg/m2 * Having given informed consent

Exclusion criteria

Exclusion criteria: * Participating in a structured (progressive) exercise program * Smoking regularly * Allergy to house dust mites or crustaceans * Diagnosed GI tract disorders or diseases * Diagnosed musculoskeletal disorders * Diagnosed metabolic disorders (e.g. diabetes) * Cardiovascular disease * Hypertension (blood pressure above 140/90 mmHg) * Donated blood 3 months prior to testday * Pregnant * Amenorrhea * Using third generation oral contraceptives * Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories). * Chronic use of gastric acid suppressing medication * Chronic use of anti-coagulants

Design outcomes

Primary

MeasureTime frame
Postprandial muscle protein synthesis rates (0-6h)

Secondary

MeasureTime frame
Postprandial muscle protein synthesis rates (0-3 en 3-6h) Plasma glucose, insuline en aminozuurconcentrations + corresponding peakvalues and (i)AUC Plasma 13C6-phenylalanine enrichments

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)